ResearcherProvidence Portland Medical CenterNo recent work listed
Paul Hansen
Matched on OpenAlex author ID A5103802459. Sources: OpenAlex.
Their work
- Papers
- 7 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 21
2014: 1 paper · 2015: none · 2016: 2 papers · 2017: none · 2018: 1 paper · 2019: none · 2020: 2 papers · 2021: 1 paper
Papers 7
- Germinal center reactions in tertiary lymphoid structures associate with neoantigen burden, humoral immunity and long-term survivorship in pancreatic cancer. Co-author DOI 10.1080/2162402x.2021.1900635↗
- Preoperative imaging characteristics predict poor survival and inadequate resection for left-sided pancreatic adenocarcinoma: a multi-institutional analysis. Co-author DOI 10.1016/j.hpb.2019.12.012↗
- Transcriptional and immunohistological assessment of immune infiltration in pancreatic cancer. Co-author DOI 10.1371/journal.pone.0238380↗
- Association of Immunologic Markers With Survival in Upfront Resectable Pancreatic Cancer. Co-author DOI 10.1001/jamasurg.2018.1757↗
- Total pancreatectomy for pancreatic ductal adenocarcinoma: review of the National Cancer Data Base. Co-author DOI 10.1016/j.hpb.2015.07.009↗
- A hypofractionated radiation regimen avoids the lymphopenia associated with neoadjuvant chemoradiation therapy of borderline resectable and locally advanced pa… Co-author DOI 10.1186/s40425-016-0149-6↗
- Neoadjuvant radiation therapy and its impact on complications after pancreaticoduodenectomy for pancreatic cancer: analysis of the American College of Surgeons… Last author DOI 10.1111/hpb.12141↗
Closest collaborators
The 21 strongest of 21 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Michael James Gough · 4 shared papers, 2016–2021 · strength 0.33
- Paper Germinal center reactions in tertiary lymphoid structures associate with neoantigen burden, humoral immunity and long-t… DOI 10.1080/2162402x.2021.1900635↗
- Paper Transcriptional and immunohistological assessment of immune infiltration in pancreatic cancer. DOI 10.1371/journal.pone.0238380↗
- Paper Association of Immunologic Markers With Survival in Upfront Resectable Pancreatic Cancer. DOI 10.1001/jamasurg.2018.1757↗
- Ephraim Shin-Tian Tang · 3 shared papers, 2018–2021 · strength 0.28
- Paper Germinal center reactions in tertiary lymphoid structures associate with neoantigen burden, humoral immunity and long-t… DOI 10.1080/2162402x.2021.1900635↗
- Paper Transcriptional and immunohistological assessment of immune infiltration in pancreatic cancer. DOI 10.1371/journal.pone.0238380↗
- Paper Association of Immunologic Markers With Survival in Upfront Resectable Pancreatic Cancer. DOI 10.1001/jamasurg.2018.1757↗
- Ronald Wolf · 4 shared papers, 2014–2018 · strength 0.25
- Paper Association of Immunologic Markers With Survival in Upfront Resectable Pancreatic Cancer. DOI 10.1001/jamasurg.2018.1757↗
- Paper Total pancreatectomy for pancreatic ductal adenocarcinoma: review of the National Cancer Data Base. DOI 10.1016/j.hpb.2015.07.009↗
- Paper A hypofractionated radiation regimen avoids the lymphopenia associated with neoadjuvant chemoradiation therapy of borde… DOI 10.1186/s40425-016-0149-6↗
- Marka R. Crittenden · 3 shared papers, 2016–2021 · strength 0.24
- Paper Germinal center reactions in tertiary lymphoid structures associate with neoantigen burden, humoral immunity and long-t… DOI 10.1080/2162402x.2021.1900635↗
- Paper Transcriptional and immunohistological assessment of immune infiltration in pancreatic cancer. DOI 10.1371/journal.pone.0238380↗
- Paper A hypofractionated radiation regimen avoids the lymphopenia associated with neoadjuvant chemoradiation therapy of borde… DOI 10.1186/s40425-016-0149-6↗
- Kristina Hoot Young · 3 shared papers, 2016–2021 · strength 0.24
- Paper Germinal center reactions in tertiary lymphoid structures associate with neoantigen burden, humoral immunity and long-t… DOI 10.1080/2162402x.2021.1900635↗
- Paper Transcriptional and immunohistological assessment of immune infiltration in pancreatic cancer. DOI 10.1371/journal.pone.0238380↗
- Paper A hypofractionated radiation regimen avoids the lymphopenia associated with neoadjuvant chemoradiation therapy of borde… DOI 10.1186/s40425-016-0149-6↗
- Zeljka Jutric · 3 shared papers, 2016–2020 · strength 0.24
- Paper Preoperative imaging characteristics predict poor survival and inadequate resection for left-sided pancreatic adenocarc… DOI 10.1016/j.hpb.2019.12.012↗
- Paper Transcriptional and immunohistological assessment of immune infiltration in pancreatic cancer. DOI 10.1371/journal.pone.0238380↗
- Paper A hypofractionated radiation regimen avoids the lymphopenia associated with neoadjuvant chemoradiation therapy of borde… DOI 10.1186/s40425-016-0149-6↗
- Terry R. Medler · 2 shared papers, 2020–2021 · strength 0.19
- Brady M. Bernard · 2 shared papers, 2020–2021 · strength 0.19
- Andrew J. Gunderson · 2 shared papers, 2020–2021 · strength 0.19
- Chet W. Hammill · 3 shared papers, 2014–2016 · strength 0.16
- Paper Total pancreatectomy for pancreatic ductal adenocarcinoma: review of the National Cancer Data Base. DOI 10.1016/j.hpb.2015.07.009↗
- Paper A hypofractionated radiation regimen avoids the lymphopenia associated with neoadjuvant chemoradiation therapy of borde… DOI 10.1186/s40425-016-0149-6↗
- Paper Neoadjuvant radiation therapy and its impact on complications after pancreaticoduodenectomy for pancreatic cancer: anal… DOI 10.1111/hpb.12141↗
- W. Cory Johnston · 2 shared papers, 2014–2016 · strength 0.11
- Eric Tran · 1 shared paper, 2021 · strength 0.10
- Farzad Alemi · 1 shared paper, 2020 · strength 0.10
- Adnan A. Alseidi · 1 shared paper, 2020 · strength 0.10
- Horacio J. Asbun · 1 shared paper, 2020 · strength 0.10
- Alexandra M. Roch · 1 shared paper, 2020 · strength 0.10
- Susanne Gray Warner · 1 shared paper, 2020 · strength 0.10
- Eugene P. Ceppa · 1 shared paper, 2020 · strength 0.10
- Todd S. Crocenzi · 1 shared paper, 2016 · strength 0.05
- Sung W. Cho · 1 shared paper, 2014 · strength 0.04
- Ching-Wei David Tzeng · 1 shared paper, 2014 · strength 0.04
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.